Delivery Order SPE2DB22D3401-SPE2DB25FT6DM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,759.51 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded with a completion date of September 9, 2025. The award was made to AmerisourceBergen's corporate office, with performance to be executed at the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,201.87 for Lupron Depot 11.25 mg 3-month kits, with an ultimate completion date of September 4, 2025. This is a firm fixed price delivery order under a non-set-aside competitive procurement. The contractor, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,750.55 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 3, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits valued at $29,864.38. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract is due for completion by July 30, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $8,203.82 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. The contract carries firm fixed price terms with no set-aside designation and is scheduled for completion by August 25, 2025. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a competitive procurement under the pharmaceutical supply chain managed by DLA Troop Support Medical....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for Lupron Depot 11.25 mg 3-month kits valued at $7,855.98 under a firm fixed-price contract. This non-set-aside delivery order is scheduled for completion by August 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement through the company's existing...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, valued at $33,612.02. This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, represents a competitively awarded, non-set-aside procurement with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Lupron Depot 11.25 mg 3-month kits, valued at $4,474.82 with a firm fixed price structure. This competitively awarded delivery order, with no set-aside designation, is scheduled for completion by August 18, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $65,364.83 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-competitive set-aside award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,913.40 for Lupron Depot 11.25 mg 3-month kits, with an ultimate completion date of July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single pharmaceutical delivery under AmerisourceBergen's broader federal medical supply portfolio. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT6DMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,483.53 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting military and federal healthcare systems through AmerisourceBergen's established supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, medical devices, and healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated extensive capability in fulfilling federal medical procurement requirements through open competition across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.5k | 9/12/25 |